ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹229 Cr | ₹227 Cr | ₹-16 Cr | ₹-197 Cr | ₹-151 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ERIS LIFESCIENCES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹229 Cr |
| Mar2024 | ₹227 Cr |
| Mar2023 | ₹-16 Cr |
| Mar2022 | ₹-197 Cr |
| Mar2021 | ₹-151 Cr |
How is Deferred Tax Assets / Liabilities of ERIS LIFESCIENCES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹229 Cr | 0.87 | |
| Mar2024 | ₹227 Cr | Positive | |
| Mar2023 | ₹-16 Cr | Negative | |
| Mar2022 | ₹-197 Cr | Negative | |
| Mar2021 | ₹-151 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹22,665.0 Cr | 6.3% | 4.9% | 23.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,034.0 Cr | 0.9% | 5.3% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,211.0 Cr | -2.3% | -3.3% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹124,875.0 Cr | -3.3% | 2.8% | 19.7% | Stock Analytics | |
| CIPLA | ₹122,082.0 Cr | -1.6% | -9.2% | 4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,873.0 Cr | NA | -3.5% | 4.6% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | 6.3% |
4.9% |
23.2% |
| SENSEX | 0.8% |
1% |
9.9% |
You may also like the below Video Courses